BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 32730642)

  • 1. The conditioned medium of human embryonic stem cell-derived mesenchymal stem cells alleviates neurological deficits and improves synaptic recovery in experimental stroke.
    Asgari Taei A; Dargahi L; Nasoohi S; Hassanzadeh G; Kadivar M; Farahmandfar M
    J Cell Physiol; 2021 Mar; 236(3):1967-1979. PubMed ID: 32730642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of angiogenesis and neurogenesis by intracerebroventricular injection of secretome from human embryonic stem cell-derived mesenchymal stem cells in ischemic stroke model.
    Asgari Taei A; Nasoohi S; Hassanzadeh G; Kadivar M; Dargahi L; Farahmandfar M
    Biomed Pharmacother; 2021 Aug; 140():111709. PubMed ID: 34020250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hippocampal neuroprotection mediated by secretome of human mesenchymal stem cells against experimental stroke.
    Asgari Taei A; Dargahi L; Khodabakhsh P; Kadivar M; Farahmandfar M
    CNS Neurosci Ther; 2022 Sep; 28(9):1425-1438. PubMed ID: 35715988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conditioned medium obtained from mesenchymal stem cells attenuates focal cerebral ischemia reperfusion injury through activation of ERK1/ERK2-BDNF signaling pathway.
    Aboutaleb N; Faezi M; Nasseri Maleki S; Nazarinia D; Razavi Tousi SMT; Hashemirad N
    J Chem Neuroanat; 2019 Apr; 97():87-98. PubMed ID: 30790626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intra-Arterial Transplantation of Allogeneic Mesenchymal Stem Cells Mounts Neuroprotective Effects in a Transient Ischemic Stroke Model in Rats: Analyses of Therapeutic Time Window and Its Mechanisms.
    Toyoshima A; Yasuhara T; Kameda M; Morimoto J; Takeuchi H; Wang F; Sasaki T; Sasada S; Shinko A; Wakamori T; Okazaki M; Kondo A; Agari T; Borlongan CV; Date I
    PLoS One; 2015; 10(6):e0127302. PubMed ID: 26075717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective Effects of Conditioned Medium of Mesenchymal Stem Cells (MSC-CM) as a Therapy for Ischemic Stroke Recovery: A Systematic Review.
    Behzadifard M; Aboutaleb N; Dolatshahi M; Khorramizadeh M; Mirshekari Jahangiri H; Kord Z; Nazarinia D
    Neurochem Res; 2023 May; 48(5):1280-1292. PubMed ID: 36581731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The membrane mesenchymal stem cell derived conditioned medium exerts neuroprotection against focal cerebral ischemia by targeting apoptosis.
    Faezi M; Nasseri Maleki S; Aboutaleb N; Nikougoftar M
    J Chem Neuroanat; 2018 Dec; 94():21-31. PubMed ID: 30121327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal stem cells with modafinil (gold nanoparticles) significantly improves neurological deficits in rats after middle cerebral artery occlusion.
    Nazarian S; Abdolmaleki Z; Torfeh A; Shirazi Beheshtiha SH
    Exp Brain Res; 2020 Nov; 238(11):2589-2601. PubMed ID: 32886135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of transplantation with bone marrow-derived mesenchymal stem cells modified by Survivin on experimental stroke in rats.
    Liu N; Zhang Y; Fan L; Yuan M; Du H; Cheng R; Liu D; Lin F
    J Transl Med; 2011 Jul; 9():105. PubMed ID: 21733181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxic conditioned medium derived from bone marrow mesenchymal stromal cells protects against ischemic stroke in rats.
    Jiang RH; Wu CJ; Xu XQ; Lu SS; Zu QQ; Zhao LB; Wang J; Liu S; Shi HB
    J Cell Physiol; 2019 Feb; 234(2):1354-1368. PubMed ID: 30076722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrical Stimulation Enhances Migratory Ability of Transplanted Bone Marrow Stromal Cells in a Rodent Ischemic Stroke Model.
    Morimoto J; Yasuhara T; Kameda M; Umakoshi M; Kin I; Kuwahara K; Kin K; Okazaki M; Takeuchi H; Sasaki T; Toyoshima A; Tajiri N; Agari T; Borlongan CV; Date I
    Cell Physiol Biochem; 2018; 46(1):57-68. PubMed ID: 29587284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of IL-10 and TNF-alpha in rats with cerebral infarction after transplantation with mesenchymal stem cells.
    Liu N; Chen R; Du H; Wang J; Zhang Y; Wen J
    Cell Mol Immunol; 2009 Jun; 6(3):207-13. PubMed ID: 19567204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal administration of human umbilical cord mesenchymal stem cells-conditioned medium enhances vascular remodeling after stroke.
    Zhao Q; Hu J; Xiang J; Gu Y; Jin P; Hua F; Zhang Z; Liu Y; Zan K; Zhang Z; Zu J; Yang X; Shi H; Zhu J; Xu Y; Cui G; Ye X
    Brain Res; 2015 Oct; 1624():489-496. PubMed ID: 26279113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic therapeutic effects of intracerebral transplantation of human modified bone marrow-derived stromal cells (SB623) and voluntary exercise with running wheel in a rat model of ischemic stroke.
    Yabuno S; Yasuhara T; Nagase T; Kawauchi S; Sugahara C; Okazaki Y; Hosomoto K; Sasada S; Sasaki T; Tajiri N; Borlongan CV; Date I
    Stem Cell Res Ther; 2023 Jan; 14(1):10. PubMed ID: 36691091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recovery of neurological function of ischemic stroke by application of conditioned medium of bone marrow mesenchymal stem cells derived from normal and cerebral ischemia rats.
    Tsai MJ; Tsai SK; Hu BR; Liou DY; Huang SL; Huang MC; Huang WC; Cheng H; Huang SS
    J Biomed Sci; 2014 Jan; 21(1):5. PubMed ID: 24447306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rat BM-MSCs secretome alone and in combination with stiripentol and ISRIB, ameliorated microglial activation and apoptosis in experimental stroke.
    Dhir N; Jain A; Sharma AR; Sharma S; Mahendru D; Patial A; Malik D; Prakash A; Attri SV; Bhattacharyya S; Das Radotra B; Medhi B
    Behav Brain Res; 2023 Jul; 449():114471. PubMed ID: 37146724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conditioned medium obtained from human amniotic mesenchymal stem cells attenuates focal cerebral ischemia/reperfusion injury in rats by targeting mTOR pathway.
    Nazarinia D; Aboutaleb N; Gholamzadeh R; Nasseri Maleki S; Mokhtari B; Nikougoftar M
    J Chem Neuroanat; 2019 Dec; 102():101707. PubMed ID: 31672459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective effect of secreted factors from human adipose stem cells in a rat stroke model.
    Seo HG; Yi Y; Oh BM; Paik NJ
    Neurol Res; 2017 Dec; 39(12):1114-1124. PubMed ID: 28948857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in host blood factors and brain glia accompanying the functional recovery after systemic administration of bone marrow stem cells in ischemic stroke rats.
    Yang M; Wei X; Li J; Heine LA; Rosenwasser R; Iacovitti L
    Cell Transplant; 2010; 19(9):1073-84. PubMed ID: 20412636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal stem cells transplantation could be beneficial for treatment of experimental ischemic stroke in rats.
    Pavlichenko N; Sokolova I; Vijde S; Shvedova E; Alexandrov G; Krouglyakov P; Fedotova O; Gilerovich EG; Polyntsev DG; Otellin VA
    Brain Res; 2008 Oct; 1233():203-13. PubMed ID: 18675258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.